Connor, Clark & Lunn Investment Management (CC&L)’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $71K | Sell |
|
|||||
|
2019
Q2 | $193K | Sell |
|
|||||
|
2019
Q1 | $349K | Sell |
|
|||||
|
2018
Q4 | $638K | Sell |
|
|||||
|
2018
Q3 | $845K | Sell |
|
|||||
|
2018
Q2 | $698K | Sell |
|
|||||
|
2018
Q1 | $655K | Sell |
|
|||||
|
2017
Q4 | $741K | Sell |
|
|||||
|
2017
Q3 | $635K | Buy |
|
|||||
|
2017
Q2 | $678K | Buy |
|
|||||
|
2017
Q1 | $498K | Buy |
|
|||||
|
2016
Q4 | $280K | Buy |
|
|||||
|
2016
Q3 | $316K | Buy |
|
|||||
|
2016
Q2 | $222K | Buy |
|
|||||
|
2016
Q1 | $215K | Sell |
|
|||||
|
2015
Q4 | $231K | Buy |
|
|||||
|
2015
Q3 | $333K | Buy |
|
|||||
|
2015
Q2 | $339K | Buy |
|
|||||
|
2015
Q1 | $341K | Buy |
|
|||||
|
2014
Q4 | $263K | Buy |
|